Are combination therapies more effective for the treatment of relapsed refractory CLL?
Managing transplant ineligible AML patients
Current projects at City of Hope: CAR T-cells, vaccines and a novel nuceloside analogue
Unmet needs in amyloidosis
Why do charities need to keep funding research into leukemia and blood cancer in general?